Background Incarcerated persons are a special population with higher hepatitis C virus
(HCV) prevalence and should be prioritized for microelimination. In this study, we investigate …

Hepatitis C virus (HCV) is one of very few viruses that are either naturally cleared, or
alternatively persist to cause chronic disease. Viral diversity and escape, as well as host …

Hepatitis C virus (HCV) can be cleared naturally in a subset of individuals. However, the
asymptomatic nature of acute HCV infection makes the study of the early immune response …

The unexplained association between infection and autoimmune disease is strongest for
hepatitis C virus-induced cryoglobulinemic vasculitis (HCV-cryovas). To analyze its origins …

Background and aims In individuals highly exposed to hepatitis C virus (HCV), reinfection is
common, suggesting that natural development of sterilising immunity is difficult. In those that …

Despite recent advances in curative therapy, hepatitis C virus (HCV) still remains a global
threat. In order to achieve global elimination, a prophylactic vaccine should be considered …

Background Hepatitis C virus (HCV) infections are more prevalent in people who inject
drugs (PWID) who often experience additional health risks. HCV induces inflammation and …

Hepatitis C (HCV) is a rapidly mutating RNA virus, with a strong propensity to cause chronic
infection and progressive liver disease. Recent evidence has shown that early appearance …

Early neutralizing antibodies against hepatitis C virus (HCV) and CD8+ T cell effector
responses can lead to viral clearance. However, these functions alone are not sufficient to …

Lack of a simple, high throughput antibody-dependent cellular phagocytosis (ADCP) assay
has limited our understanding of its potential role of in hepatitis C (HCV) infection. Here, we …